Related Experiment Video
Updated: Mar 16, 2026

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
10.4K
Patterns of disease relapse in primary extremity soft-tissue sarcoma
H G Smith1, N Memos1, J M Thomas1
1The Sarcoma Unit, Department of Academic Surgery, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
The British Journal of Surgery
|August 10, 2016
Summary
Histological subtype impacts metastasis patterns in extremity soft-tissue sarcoma, but not overall survival. Understanding these differences aids in predicting disease spread and tailoring patient care for better outcomes.
Area of Science:
- Orthopedic Oncology
- Surgical Pathology
- Cancer Epidemiology
Background:
- Extremity soft-tissue sarcomas encompass diverse histological subtypes.
- Characterizing relapse patterns is crucial for managing these rare tumors.
Purpose of the Study:
- To analyze disease relapse patterns in patients with primary extremity soft-tissue sarcoma.
- To investigate the prognostic impact of histological subtype on survival outcomes.
Main Methods:
- Retrospective analysis of 556 patients undergoing resection at a single institution (2004-2014).
- Evaluation of local recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), and disease-specific survival (DSS).
- Multivariable analysis to determine independent prognostic factors.
Main Results:
- Undifferentiated pleomorphic sarcoma showed the poorest outcomes (5-year DMFS 56.8%, DSS 60.1%).
- Histological subtype significantly impacted DMFS and DSS (P < 0.001), but not LRFS (P = 0.222).
- Lungs were the most common site of metastasis (80.5%), but extrapulmonary metastases were more frequent in myxoid liposarcoma.
Conclusions:
- Histological subtype is not an independent prognostic factor for LRFS, DMFS, or DSS.
- The site of first metastasis significantly varies by histological subtype.
- Findings highlight the importance of considering subtype-specific metastatic patterns in treatment strategies.
Related Concept Videos
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K

